![Uwe Klein](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Uwe Klein
Företagsledare/Principal på
SEPTERNA, INC.
Förmögenhet: 4 M $ per 2026-07-31
Profil
Uwe Klein currently works at Septerna, Inc., as Senior Vice President-Biological Sciences from 2021.
Dr. Klein also formerly worked at Theravance Biopharma, Inc., as Senior Director-Molecular & Cellular Biology from 1998 to 2014, Bristol Myers Squibb Co., as Vice President-Biology from 2020 to 2021, MyoKardia, Inc., as Vice President-Biology from 2019 to 2020, and Numerate, Inc., as Vice President-Biology from 2014 to 2019.
Dr. Klein received his undergraduate degree, graduate degree, and doctorate degree from Johann Wolfgang Goethe-Universität Frankfurt am Main.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
SEPTERNA, INC. 0,28 % | 2026-02-06 | 127 533 ( 0,28 % ) | 4 M $ | 2026-07-31 |
Aktiva positioner av Uwe Klein
| Företag | Position | Start |
|---|---|---|
| SEPTERNA, INC. | Företagsledare/Principal | 2021-08-01 |
Tidigare kända positioner av Uwe Klein
| Företag | Position | Slut |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Företagsledare/Principal | 2021-03-01 |
| MYOKARDIA, INC. | Företagsledare/Principal | 2020-11-01 |
Numerate, Inc.
 Numerate, Inc. Packaged SoftwareTechnology Services Develops drug engineering platform | Företagsledare/Principal | 2019-09-01 |
| THERAVANCE BIOPHARMA, INC. | Företagsledare/Principal | 2014-10-01 |
Uwe Kleins utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
58
Första gradens relationer
6
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 6 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
MyoKardia, Inc.
 MyoKardia, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of cardiovascular diseases | Health Technology |
Johann Wolfgang Goethe-Universität Frankfurt am Main
 Johann Wolfgang Goethe-Universität Frankfurt am Main Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Numerate, Inc.
Numerate, Inc. Packaged SoftwareTechnology Services Develops drug engineering platform | Technology Services |
Theravance Biopharma, Inc.
 Theravance Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of human therapeutics products for respiratory diseases | Health Technology |
Septerna, Inc.
 Septerna, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that discovers and develops G protein-coupled receptor oral small molecule products for the treatment of hypoparathyroidism | Health Technology |
